If you’re 60 years and older, you may be at risk of infection from RSV. AREXVY can help protect you.

How does AREXVY work?

AREXVY is designed to help the immune system make antibodies and white blood cells that target both subtypes of RSV (RSV-A and RSV-B).

As AREXVY does not contain the RSV virus, it cannot cause an infection.

As with all vaccines, AREXVY may not fully protect all people who are vaccinated.

How to take AREXVY

Icon of a single injection into upper arm

AREXVY is given as a single injection of 0.5 mL into a muscle (usually in the upper arm).

Icon of two vials and a needle

AREXVY may be given at the same time as a seasonal flu vaccine.

Icon of the body

If AREXVY is given at the same time as another vaccine, a different injection site will be used for each vaccine.

WHAT ARE POSSIBLE SIDE EFFECTS OF AREXVY?

Like all medicines, AREXVY can cause side effects, although not everyone experiences them.

Most side effects are mild or moderate and do not last long (usually 1 to 2 days). The following side effects may occur after receiving AREXVY. These are not all the possible side effects.

VERY COMMON

(these may occur with more than 1 in 10 doses of the vaccine):

Pain icon

Pain at the injection site

Tiredness icon

Tiredness

Headache icon

Headache

Joint pain icon

Muscle pain (myalgia) and joint pain (arthralgia)

COMMON

(these may occur with up to 1 in 10 doses of the vaccine):

  • Redness and swelling at the injection site, fever, chills
  • Runny nose (rhinorrhea)

UNCOMMON

(these may occur with up to 1 in 100 doses of the vaccine):

  • Injection site itching (pruritus), pain, generally feeling unwell
  • Swelling of lymph nodes (lymphadenopathy)
  • Allergic reaction, such as rash
  • Feeling sick (nausea), stomach pain
Virus icon

WHAT IS RSV?

RSV is a common and contagious respiratory virus that affects the lungs and respiratory airways.

ABOUT RSV
Question mark icon

WANT TO LEARN MORE?

Find answers to frequently asked questions about RSV and getting vaccinated.

About Arexvy

AREXVY is a vaccine that helps to protect adults 60 years of age and older from lower lung disease caused by respiratory syncytial virus (RSV). 100% protection cannot be guaranteed. AREXVY is not indicated for the treatment of RSV and does not prevent or reduce the risk of complications. AREXVY should not be used if you are allergic to any ingredient in the vaccine. Adverse events may occur. Very common adverse events (≥10% of doses) reported in clinical trials were pain at the injection site, tiredness, headache, muscle pain (myalgia), and joint pain (arthralgia). Ask your healthcare professional if AREXVY is right for you. Full product information can be found at gsk.ca/arexvy/en. To report an adverse event, please call 1-800-387-7374.